heapsreal
iherb 10% discount code OPA989,
- Messages
- 10,089
- Location
- australia (brisbane)
: These findings from a prospectively defined analysis of a large randomized trial confirm CD56bright NK cell counts as a DAC HYP efficacy biomarker and further support their immunomodulatory role in RRMS. http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S31.004
RRMS is relapsing and remitting multiple sclerosis.
This is the same biomarker PHANU have found in cfs/me.
I dont quite understand this study, i think its saying those with a better nk bright cell numbers had fewer lesions. Daclizumab HYP Treatment is a monoclonal antibodies and this improves nk bright cells??
Could this DAC HYP be a treatment to improve nk function in cfs/me??
Trying to find more on this DAC HYP if someone can help me out?
ALso someone with a better mind then me could make more sense of the study for the rest of us to understand would be great too?
RRMS is relapsing and remitting multiple sclerosis.
This is the same biomarker PHANU have found in cfs/me.
I dont quite understand this study, i think its saying those with a better nk bright cell numbers had fewer lesions. Daclizumab HYP Treatment is a monoclonal antibodies and this improves nk bright cells??
Could this DAC HYP be a treatment to improve nk function in cfs/me??
Trying to find more on this DAC HYP if someone can help me out?
ALso someone with a better mind then me could make more sense of the study for the rest of us to understand would be great too?